Biocon Leads Race for Generic Weight Loss Drugs
Biocon's semaglutide-based drugs, Ozempic and Wegovy, are competing with Eli Lilly's tirzepatide-based Zepbound in the blockbuster weight loss drug race.
Read Full News: Hindustan Times :: Economics Times :: Republic World